NASDAQ
Innate Pharma S.A. (IPHA) has a fcf yield of -26.21% as of Monday, August 3, 2026. This represents a 120.74% decrease compared to its 12-month average of -11.88%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.